Insulin Regulation of Hepatic Lipid Homeostasis
Authors:
- 26 June 2023
- journal article
- Published by Wiley in Comprehensive Physiology
- Vol. 13 (3) , 4785-4809
Abstract
The incidence of obesity, insulin resistance, and type II diabetes (T2DM) continues to rise worldwide. The liver is a central insulin‐responsive metabolic organ that governs whole‐body metabolic homeostasis. Therefore, defining the mechanisms underlying insulin action in the liver is essential to our understanding of the pathogenesis of insulin resistance. During periods of fasting, the liver catabolizes fatty acids and stored glycogen to meet the metabolic demands of the body. In postprandial conditions, insulin signals to the liver to store excess nutrients into triglycerides, cholesterol, and glycogen. In insulin‐resistant states, such as T2DM, hepatic insulin signaling continues to promote lipid synthesis but fails to suppress glucose production, leading to hypertriglyceridemia and hyperglycemia. Insulin resistance is associated with the development of metabolic disorders such as cardiovascular and kidney disease, atherosclerosis, stroke, and cancer. Of note, nonalcoholic fatty liver disease (NAFLD), a spectrum of diseases encompassing fatty liver, inflammation, fibrosis, and cirrhosis, is linked to abnormalities in insulin‐mediated lipid metabolism. Therefore, understanding the role of insulin signaling under normal and pathologic states may provide insights into preventative and therapeutic opportunities for the treatment of metabolic diseases. Here, we provide a review of the field of hepatic insulin signaling and lipid regulation, including providing historical context, detailed molecular mechanisms, and address gaps in our understanding of hepatic lipid regulation and the derangements under insulin‐resistant conditions. © 2023 American Physiological Society. Compr Physiol 13:4785‐4809, 2023.Keywords
This publication has 354 references indexed in Scilit:
- Fatty Acid Synthase Inhibitor TVB‐2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic AbnormalitiesHepatology, 2019
- Hepatocyte Deletion of Triglyceride‐Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in MiceHepatology, 2019
- Mechanisms of AMPK in the maintenance of ATP balance during energy metabolismCell Biology International, 2018
- Increased Fructose Consumption Is Associated With Fibrosis Severity in Patients With Nonalcoholic Fatty Liver DiseaseHepatology, 2010
- Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice #Hepatology, 2009
- Molecular Physiology of Mammalian GlucokinaseCellular and Molecular Life Sciences, 2008
- Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†Hepatology, 2005
- Mutant Mammalian Cells as Tools to Delineate the Sterol Regulatory Element-Binding Protein Pathway for Feedback Regulation of Lipid SynthesisArchives of Biochemistry and Biophysics, 2002
- A Receptor‐Mediated Pathway for Cholesterol Homeostasis (Nobel Lecture)Angewandte Chemie International Edition, 1986
- Effect of (−)‐hydroxycitrate upon the accumulation of lipid in the rat: I. LipogenesisLipids, 1974